Literature DB >> 11971698

19F, (1)H-HOESY and PGSE NMR studies of neutral trinuclear complexes of Au(I) and Hg(II): evidence for acid-base stacking in solution.

Alfredo Burini1, John P Fackler, Rossana Galassi, Alceo Macchioni, Mohammad A Omary, Manal A Rawashdeh-Omary, Bianca R Pietroni, Stefano Sabatini, Cristiano Zuccaccia.   

Abstract

By combining the information from 19F, 1H-HOESY and PGSE NMR methodologies, unprecedented direct evidence has been obtained for the formation of supramolecular assemblies in solution between the trinuclear cyclic AuI basic compounds ([Au(mu-C2,N3-bzim)]3 (bzim = 1-benzylimidazolate), 1, and [Au(mu-C,N-C(OEt)=N-p-C6H4-CH3)]3, 2, on one hand, and the trinuclear cyclic HgII acid complex [Hg(mu-C,C-C6F4)]3, 3, on the other hand. HOESY experiments indicate that a stacking similar to that observed in the solid state occurs. PGSE studies demonstrate the presence of an equilibrium between the free trinuclear entities and adduct A in the case of 2/3 admixtures (see Sketch) while for 1/3 admixtures, adducts A and B are mainly present in solution.

Year:  2002        PMID: 11971698     DOI: 10.1021/ja0174837

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  2 in total

1.  Hydrogen bonding and anticancer properties of water-soluble chiral p-cymene Ru(II) compounds with amino-oxime ligands.

Authors:  Yosra Benabdelouahab; Laura Muñoz-Moreno; Malgorzata Frik; Isabel de la Cueva-Alique; Mohammed Amin El Amrani; María Contel; Ana M Bajo; Tomás Cuenca; Eva Royo
Journal:  Eur J Inorg Chem       Date:  2015-04-09       Impact factor: 2.524

2.  Donor-acceptor interactions between cyclic trinuclear pyridinate gold(i)-complexes and electron-poor guests: nature and energetics of guest-binding and templating on graphite.

Authors:  Raiko Hahn; Fabian Bohle; Stefan Kotte; Tristan J Keller; Stefan-S Jester; Andreas Hansen; Stefan Grimme; Birgit Esser
Journal:  Chem Sci       Date:  2018-03-05       Impact factor: 9.825

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.